The sleep apnea market is about to change forever.
#$IXHL will be one of the first to offer alternative therapies to a condition that affects millions globally. It also enters a market that is a near monopoly.
Read: haphestus.com/ixhl-a-deep-...
#stocks #finance
#$IXHL will be one of the first to offer alternative therapies to a condition that affects millions globally. It also enters a market that is a near monopoly.
Read: haphestus.com/ixhl-a-deep-...
#stocks #finance
IXHL: A Deep Dive | Haphestus
Exploring IXHL, its sleep apnea drug IHL-42X, global market size and why this biotech offers a unique asymmetric investment setup.
haphestus.com
January 21, 2026 at 6:31 PM
The sleep apnea market is about to change forever.
#$IXHL will be one of the first to offer alternative therapies to a condition that affects millions globally. It also enters a market that is a near monopoly.
Read: haphestus.com/ixhl-a-deep-...
#stocks #finance
#$IXHL will be one of the first to offer alternative therapies to a condition that affects millions globally. It also enters a market that is a near monopoly.
Read: haphestus.com/ixhl-a-deep-...
#stocks #finance
We called these plays early and the results speak for themselves
$FMTO +1071%
$NAOV +451%
$ZVSA +207%
$GLXG +195%
$VERO +191%
$IXHL +177%
$BTOG +161%
$SXTP +139%
$SVRE +116%
$ONCO +110%
$FMTO +1071%
$NAOV +451%
$ZVSA +207%
$GLXG +195%
$VERO +191%
$IXHL +177%
$BTOG +161%
$SXTP +139%
$SVRE +116%
$ONCO +110%
April 8, 2025 at 8:51 PM
We called these plays early and the results speak for themselves
$FMTO +1071%
$NAOV +451%
$ZVSA +207%
$GLXG +195%
$VERO +191%
$IXHL +177%
$BTOG +161%
$SXTP +139%
$SVRE +116%
$ONCO +110%
$FMTO +1071%
$NAOV +451%
$ZVSA +207%
$GLXG +195%
$VERO +191%
$IXHL +177%
$BTOG +161%
$SXTP +139%
$SVRE +116%
$ONCO +110%
“WHY ASBESTOS?” 1970 ASBESTOS INFORMATION COMMITTEE PROPAGANDA FILM XD52424 www.youtube.com/watch?v=IXHl...
“WHY ASBESTOS?” 1970 ASBESTOS INFORMATION COMMITTEE PROPAGANDA FILM XD52424
Join this channel to get access to perks:https://www.youtube.com/channel/UCddem5RlB3bQe99wyY49g0g/joinWant to learn more about Periscope Film and get access ...
www.youtube.com
April 2, 2024 at 1:24 AM
“WHY ASBESTOS?” 1970 ASBESTOS INFORMATION COMMITTEE PROPAGANDA FILM XD52424 www.youtube.com/watch?v=IXHl...
#IXHL Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million in Non-Dilutive Capital Received in 2026
https://www.stocktitan.net/news/IXHL/incannex-receives-additional-a-5-1-million-r-d-tax-incentive-refund-5tgd6n67qiku.html
https://www.stocktitan.net/news/IXHL/incannex-receives-additional-a-5-1-million-r-d-tax-incentive-refund-5tgd6n67qiku.html
Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million in Non-Dilutive Capital Received in 2026
Incannex Healthcare Inc.
www.stocktitan.net
August 11, 2026 at 12:00 PM
#IXHL Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million in Non-Dilutive Capital Received in 2026
https://www.stocktitan.net/news/IXHL/incannex-receives-additional-a-5-1-million-r-d-tax-incentive-refund-5tgd6n67qiku.html
https://www.stocktitan.net/news/IXHL/incannex-receives-additional-a-5-1-million-r-d-tax-incentive-refund-5tgd6n67qiku.html
#IXHL Incannex Announces Initiation of Research Coverage by Alliance Global Partners
https://www.stocktitan.net/news/IXHL/incannex-announces-initiation-of-research-coverage-by-alliance-nvdv309p1o5h.html
https://www.stocktitan.net/news/IXHL/incannex-announces-initiation-of-research-coverage-by-alliance-nvdv309p1o5h.html
Incannex Announces Initiation of Research Coverage by Alliance Global Partners
Incannex (Nasdaq: IXHL) announced that Alliance Global Partners has initiated equity research coverage with a BUY rating and a US$18.00 price target, in a report dated June 8, 2026 by analyst James Molloy.The coverage evaluates Incannex’s clinical pipeline, including IHL-42X for obstructive sleep apnoea and PSX-001 for generalized anxiety disorder, and is expected by the company to broaden investor awareness. AGP has received compensation from Incannex for investment banking services.
www.stocktitan.net
June 9, 2026 at 12:00 PM
#IXHL Incannex Announces Initiation of Research Coverage by Alliance Global Partners
https://www.stocktitan.net/news/IXHL/incannex-announces-initiation-of-research-coverage-by-alliance-nvdv309p1o5h.html
https://www.stocktitan.net/news/IXHL/incannex-announces-initiation-of-research-coverage-by-alliance-nvdv309p1o5h.html
NEWS: ( NASDAQ: #IXHL ) FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed
#StockMarket #News
#StockMarket #News
August 5, 2024 at 2:30 PM
#IXHL Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea
https://www.stocktitan.net/news/IXHL/incannex-receives-positive-patient-reported-outcomes-and-compelling-snf40wlb3a92.html
https://www.stocktitan.net/news/IXHL/incannex-receives-positive-patient-reported-outcomes-and-compelling-snf40wlb3a92.html
Revolutionary Sleep Apnea Drug Shows 83% Improvement in Phase 2 Trial, Patients Report Life-Changing Benefits
New sleep apnea treatment achieves unprecedented 83% symptom reduction in clinical trial. Patient interviews reveal dramatic quality of life improvements. See full results.
www.stocktitan.net
August 8, 2025 at 12:00 PM
#IXHL Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea
https://www.stocktitan.net/news/IXHL/incannex-receives-positive-patient-reported-outcomes-and-compelling-snf40wlb3a92.html
https://www.stocktitan.net/news/IXHL/incannex-receives-positive-patient-reported-outcomes-and-compelling-snf40wlb3a92.html
We asked the Stocktwits community a simple question: What’s your top stock idea for 2026?
1100+ replies later, here’s what stood out:
$CAPR $ASTS $APLD $SOFI $RIVN $LUNR $NVDA $RKLB $NBIS $PLTR $SLS $RZLV $BYND $TMC $POET $IXHL $QNCCF $IOVA $ONDS $NLST
1100+ replies later, here’s what stood out:
$CAPR $ASTS $APLD $SOFI $RIVN $LUNR $NVDA $RKLB $NBIS $PLTR $SLS $RZLV $BYND $TMC $POET $IXHL $QNCCF $IOVA $ONDS $NLST
December 31, 2025 at 3:05 PM
We asked the Stocktwits community a simple question: What’s your top stock idea for 2026?
1100+ replies later, here’s what stood out:
$CAPR $ASTS $APLD $SOFI $RIVN $LUNR $NVDA $RKLB $NBIS $PLTR $SLS $RZLV $BYND $TMC $POET $IXHL $QNCCF $IOVA $ONDS $NLST
1100+ replies later, here’s what stood out:
$CAPR $ASTS $APLD $SOFI $RIVN $LUNR $NVDA $RKLB $NBIS $PLTR $SLS $RZLV $BYND $TMC $POET $IXHL $QNCCF $IOVA $ONDS $NLST
$PHIO signed a US drug‑substance development and CGMP manufacturing deal for its lead INTASYL siRNA candidate PH‑762
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2025/18...
$ATNF $PHIO $IXHL $LYEL $NXTC $ABSI $ACXP $SRPT $EW
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2025/18...
$ATNF $PHIO $IXHL $LYEL $NXTC $ABSI $ACXP $SRPT $EW
July 25, 2025 at 12:25 PM
$PHIO signed a US drug‑substance development and CGMP manufacturing deal for its lead INTASYL siRNA candidate PH‑762
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2025/18...
$ATNF $PHIO $IXHL $LYEL $NXTC $ABSI $ACXP $SRPT $EW
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2025/18...
$ATNF $PHIO $IXHL $LYEL $NXTC $ABSI $ACXP $SRPT $EW
$ LYEL entered a private placement with institutional and accredited investors to raise up to $100 million ($50 million upfront) by selling shares at $13.32
See More Biotech Updates👇
www.biopharmcatalyst.com/news/2025/in...
$ATNF $IXHL $LYEL $NXTC $ABSI $ACXP $SRPT
See More Biotech Updates👇
www.biopharmcatalyst.com/news/2025/in...
$ATNF $IXHL $LYEL $NXTC $ABSI $ACXP $SRPT
July 25, 2025 at 8:20 PM
$ LYEL entered a private placement with institutional and accredited investors to raise up to $100 million ($50 million upfront) by selling shares at $13.32
See More Biotech Updates👇
www.biopharmcatalyst.com/news/2025/in...
$ATNF $IXHL $LYEL $NXTC $ABSI $ACXP $SRPT
See More Biotech Updates👇
www.biopharmcatalyst.com/news/2025/in...
$ATNF $IXHL $LYEL $NXTC $ABSI $ACXP $SRPT
Most searched small-cap stocks, Wed May 14th - #SMR #CLSK #QUBT #VLRS #APLD #GENI #RIG #SEPN #ICCT #MLGO #RXRX #RGTI #QBTS #ONDS #LUNR #IXHL #IDR #HL #RUN #ASST - More: crystalequityresearch.com/SmCpStr/ - #smallcap
SmCpStr Technicals – Technical Indicators for Small-cap Stocks
crystalequityresearch.com
May 15, 2025 at 1:17 AM
.. Malaysia ... IL
Malaysia Exposes A MAJOR Israel Weakness
- Tel Aviv Is Freaking Out!
www.youtube.com/watch?v=Ixhl...
Malaysia Exposes A MAJOR Israel Weakness
- Tel Aviv Is Freaking Out!
www.youtube.com/watch?v=Ixhl...
Malaysia Exposes A MAJOR Israel Weakness - Tel Aviv Is Freaking Out!
YouTube video by KernowDamo
www.youtube.com
September 18, 2026 at 9:52 AM
.. Malaysia ... IL
Malaysia Exposes A MAJOR Israel Weakness
- Tel Aviv Is Freaking Out!
www.youtube.com/watch?v=Ixhl...
Malaysia Exposes A MAJOR Israel Weakness
- Tel Aviv Is Freaking Out!
www.youtube.com/watch?v=Ixhl...
Malaysia Exposes A MAJOR Israel Weakness - Tel Aviv Is Freaking Out! - YouTube www.youtube.com/watch?v=Ixhl...
Malaysia Exposes A MAJOR Israel Weakness - Tel Aviv Is Freaking Out!
YouTube video by KernowDamo
www.youtube.com
September 18, 2026 at 8:16 AM
Malaysia Exposes A MAJOR Israel Weakness - Tel Aviv Is Freaking Out! - YouTube www.youtube.com/watch?v=Ixhl...
$MCVT +220% intraday, $IXHL +6% AH, China auto parts surging w/ $27.5M M&A 💼 Micro float + biotech catalyst = squeeze setups 🔥 Watch: www.youtube.com/@StockTradeX Join: discord.gg/TvxGNK7gvq
StockTradeX
JOIN STOCK TRADE X Membership
🛑 https://discord.gg/TvxGNK7gvq 🛑
Stock Trade X is your go-to source for **stock market analysis, trading strategies, and momentum plays**. Stay ahead with **catalyst-d...
www.youtube.com
July 26, 2025 at 2:02 AM
$MCVT +220% intraday, $IXHL +6% AH, China auto parts surging w/ $27.5M M&A 💼 Micro float + biotech catalyst = squeeze setups 🔥 Watch: www.youtube.com/@StockTradeX Join: discord.gg/TvxGNK7gvq
#IXHL Incannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital Position
https://www.stocktitan.net/news/IXHL/incannex-healthcare-provides-corporate-update-on-clinical-progress-2l9qyaba80b9.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/IXHL/incannex-healthcare-provides-corporate-update-on-clinical-progress-2l9qyaba80b9.html?utm_source=stocktitan-bluesky&utm_medium=social
Incannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital Position
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
September 9, 2026 at 12:00 PM
#IXHL Incannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital Position
https://www.stocktitan.net/news/IXHL/incannex-healthcare-provides-corporate-update-on-clinical-progress-2l9qyaba80b9.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/IXHL/incannex-healthcare-provides-corporate-update-on-clinical-progress-2l9qyaba80b9.html?utm_source=stocktitan-bluesky&utm_medium=social
🚨 $IXHL
On September 9, 2026, Incannex Healthcare Inc. issued the press release furnished as Exhibit 99.1. The information contained in Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section...
On September 9, 2026, Incannex Healthcare Inc. issued the press release furnished as Exhibit 99.1. The information contained in Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section...
SEC Filing: IXHL
Click to view the official SEC document.
www.sec.gov
September 9, 2026 at 11:30 AM
🚨 $IXHL
On September 9, 2026, Incannex Healthcare Inc. issued the press release furnished as Exhibit 99.1. The information contained in Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section...
On September 9, 2026, Incannex Healthcare Inc. issued the press release furnished as Exhibit 99.1. The information contained in Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section...
🚨 $IXHL
On August 25, 2026, Incannex Healthcare Inc. issued the press release furnished as Exhibit 99.1. The information contained in Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 1...
On August 25, 2026, Incannex Healthcare Inc. issued the press release furnished as Exhibit 99.1. The information contained in Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 1...
SEC Filing: IXHL
Click to view the official SEC document.
www.sec.gov
August 25, 2026 at 11:31 AM
🚨 $IXHL
On August 25, 2026, Incannex Healthcare Inc. issued the press release furnished as Exhibit 99.1. The information contained in Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 1...
On August 25, 2026, Incannex Healthcare Inc. issued the press release furnished as Exhibit 99.1. The information contained in Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 1...
#IXHL Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X
https://www.stocktitan.net/news/IXHL/incannex-announces-first-patient-dosed-in-d-re-a-mzz-phase-2-study-yejftxjf05y4.html
https://www.stocktitan.net/news/IXHL/incannex-announces-first-patient-dosed-in-d-re-a-mzz-phase-2-study-yejftxjf05y4.html
Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X
Incannex Healthcare (Nasdaq: IXHL) reported that the first patient has been dosed in DReAMzz, its Phase 2 crossover dose-optimization study of IHL-42X, an oral fixed-dose combination of dronabinol and acetazolamide for obstructive sleep apnea (OSA). All 14 U.S. trial sites have Institutional Review Board approval, drug product has been manufactured, and patient screening is underway.According to Incannex, IHL-42X previously showed statistically significant reductions in apnea-hypopnea index (AHI) versus placebo in the Phase 2 RePOSA study, with individual AHI reductions up to 83% and an exceptional safety profile. IHL-42X has received FDA Fast Track designation, and DReAMzz is intended to refine dose selection and support a planned Phase 3 program.
www.stocktitan.net
August 25, 2026 at 12:46 PM
#IXHL Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X
https://www.stocktitan.net/news/IXHL/incannex-announces-first-patient-dosed-in-d-re-a-mzz-phase-2-study-yejftxjf05y4.html
https://www.stocktitan.net/news/IXHL/incannex-announces-first-patient-dosed-in-d-re-a-mzz-phase-2-study-yejftxjf05y4.html
🚨 $IXHL
On August 11, 2026, Incannex Healthcare Inc. issued the press release furnished as Exhibit 99.1. The information contained in Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 1...
On August 11, 2026, Incannex Healthcare Inc. issued the press release furnished as Exhibit 99.1. The information contained in Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 1...
SEC Filing: IXHL
Click to view the official SEC document.
www.sec.gov
August 11, 2026 at 11:31 AM
🚨 $IXHL
On August 11, 2026, Incannex Healthcare Inc. issued the press release furnished as Exhibit 99.1. The information contained in Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 1...
On August 11, 2026, Incannex Healthcare Inc. issued the press release furnished as Exhibit 99.1. The information contained in Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 1...
🚨 $IXHL
On July 23, 2026, Incannex Healthcare Inc. issued the press release furnished as Exhibit 99.1. The information contained in Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 ...
On July 23, 2026, Incannex Healthcare Inc. issued the press release furnished as Exhibit 99.1. The information contained in Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 ...
SEC Filing: IXHL
Click to view the official SEC document.
www.sec.gov
July 23, 2026 at 11:31 AM
🚨 $IXHL
On July 23, 2026, Incannex Healthcare Inc. issued the press release furnished as Exhibit 99.1. The information contained in Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 ...
On July 23, 2026, Incannex Healthcare Inc. issued the press release furnished as Exhibit 99.1. The information contained in Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 ...